Impact of intravenous thrombolysis on length of hospital stay in cases of acute ischemic stroke

被引:10
|
作者
Kasemsap, Narongrit [1 ,2 ]
Vorasoot, Nisa [1 ,2 ]
Kongbunkiat, Kannikar [1 ,2 ]
Peansukwech, Udomlack [1 ]
Tiamkao, Somsak [1 ,2 ]
Sawanyawisuth, Kittisak [1 ,2 ,3 ,4 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Med, 123 Mitraparp Highway, Khon Kaen 40002, Thailand
[2] Khon Kaen Univ, North Eastern Stroke Res Grp, Khon Kaen, Thailand
[3] Khon Kaen Univ, Res Ctr Back Neck Other Joint Pain & Human Perfor, Khon Kaen, Thailand
[4] Khon Kaen Univ, Internal Med Res Grp, Khon Kaen, Thailand
来源
关键词
acute ischemic stroke; length of stay; thrombolysis; TISSUE-PLASMINOGEN ACTIVATOR; OF-STAY; ATRIAL-FIBRILLATION; MEDICAL COMPLICATIONS; NATIONAL DATA; OUTCOMES; MORTALITY; NETHERLANDS; PREDICTOR; PNEUMONIA;
D O I
10.2147/NDT.S151836
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: There are limited data available on factors associated with length of stay (LOS) in cases of acute ischemic stroke according to Poisson analysis, which is more appropriate than other methods. Materials and methods: We retrospectively reviewed medical summary charts of patients with acute ischemic stroke in 30 hospitals across northeast Thailand, with the main outcome as LOS. Poisson regression was used to examine factors associated with LOS. Results: We included 898 patients in the analysis; 460 (51.2%) were male. The median age (interquartile; IQR) was 58 (67-75) years and the median LOS was 5 (4-7) days. The median National Institute of Health Stroke Scale (NIHSS [IQR]) was 8 (4-13). Results of the analysis showed that, after controlling for age, stroke severity, atrial fibrillation, and thrombolytic use, significant variables associated with LOS were moderate stroke (incidence rate ratio [IRR] 95% confidence interval [CI] = 1.15 [range 1.01-1.30], P = 0.040), severe stroke (IRR [95% CI] = 1.27 [1.09-1.47], P = 0.002), thrombolytic use (IRR [95% CI] = 0.68 [0.60-0.76], P > 0.001), and atrial fibrillation (IRR [95% CI] = 1.15 [1.02-1.30], P = 0.023). After adjusting for complications, thrombolytic use remained significantly associated with decreased LOS (IRR [95% CI] = 0.74 [0.67-0.83], P = 0.001). Other significant factors were atrial fibrillation (IRR [95% CI] = 1.14 [1.02-1.28], P = 0.018), pneumonia (IRR [95% CI] = 1.48 [1.30-1.68], P < 0.001), and urinary tract infection (IRR [95% CI] = 1.41 [1.14-1.74], P = 0.001). Conclusion: According to Poisson analysis, intravenous thrombolysis, atrial fibrillation, pneumonia, and urinary tract infection are associated with LOS in cases of acute ischemic stroke, regardless of age, stroke severity, comorbidities, or complications.
引用
收藏
页码:259 / 263
页数:5
相关论文
共 50 条
  • [41] The impact of selected cardiovascular factors on the safety and efficacy of intravenous thrombolysis for acute ischemic stroke in routine practice in a rural hospital
    Wach-Klink, Aleksandra
    Paciura, Karol
    Zwadowska, Alicja
    Adamczak, Malgorzata
    Strojewska, Wioletta
    Franczak-Prochowski, Tadeusz
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2018, 34 (03) : 232 - 240
  • [42] Prolonged Hospital Length of Stay Does Not Improve Functional Outcome in Acute Ischemic Stroke
    Lu, Yuxuan
    Sun, Peng
    Jin, Haiqiang
    Wang, Zhaoxia
    Shen, Zhiyuan
    Sun, Wei
    Sun, Yongan
    Liu, Ran
    Li, Fan
    Shu, Junlong
    Qiu, Zifeng
    Lu, Zhongbing
    Sun, Weiping
    Zhu, Sainan
    Huang, Yining
    NEUROLOGY AND THERAPY, 2025, 14 (02) : 593 - 607
  • [43] Do early laboratory parameters in acute ischemic stroke influence hospital length of stay?
    Stead, LG
    Decker, WW
    Weaver, AL
    Brown, RD
    ANNALS OF NEUROLOGY, 2004, 56 : S46 - S46
  • [44] Impact of Hemoglobin Levels on the Functional Outcome in Acute Ischemic Stroke after Intravenous Thrombolysis
    Kim, Chi Kyung
    Jung, Seunguk
    Kim, Yerim
    Ko, Sang-Bae
    Lee, Seung-Hoon
    Yoon, Byung-Woo
    CEREBROVASCULAR DISEASES, 2013, 36 : 41 - 41
  • [45] Sulfonylurea Pretreatment Does Not Impact Acute Ischemic Stroke Outcomes Following Intravenous Thrombolysis
    Tsivgoulis, Georgios
    Goyal, Nitin
    Zand, Ramin
    Male, Shailesh
    Iftikhar, Sulaiman
    Chang, Jason
    Elijovich, Lucas
    Alexandrov, Anne W.
    Malkoff, Marc D.
    Alexandrov, Andrei, V
    STROKE, 2016, 47
  • [46] Impact of Hemoglobin Levels on the Functional Outcome in Acute Ischemic Stroke after Intravenous Thrombolysis
    Jung, Seunguk
    Kim, Chi-Kyung
    Kim, Yerim
    Ko, Sang-Bae
    Lee, Seung-Hoon
    Yoon, Byung-Woo
    CEREBROVASCULAR DISEASES, 2014, 38 : 29 - 30
  • [47] Intravenous thrombolysis for acute ischemic stroke. A four years' experience in a Chilean public hospital
    Soto, Alvaro, V
    Morales, Gladys, I
    Grandjean B, Marcela
    Pollak W, Debora
    Del Castillo C, Carolina
    Garcia, Pia
    Von Johnn A, Alexis
    Riquelme G, Alfonso
    REVISTA MEDICA DE CHILE, 2017, 145 (04) : 468 - 475
  • [48] Cerebral microbleeds in acute ischemic stroke after intravenous thrombolysis and their impact on short term outcome of stroke
    Oraby, Mohammed I.
    Gomaa, Rana
    Abdel-Aal, Ahmed A.
    Hussein, Mona
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024,
  • [49] Refusal of Intravenous Thrombolysis for Acute Ischemic Stroke in San Diego
    von Kleist, Tara
    Meyer, Dawn
    Rapp, Karen
    Meyer, Brett
    Modir, Royya
    STROKE, 2020, 51
  • [50] Current status of intravenous thrombolysis for acute ischemic stroke in Asia
    Sharma, Vijay K.
    Ng, Kay W. P.
    Venketasubramanian, Narayanaswamy
    Saqqur, Maher
    Teoh, Hock L.
    Kaul, Subash
    Srivastava, Padma M. V.
    Sergentanis, Theodoris
    Suwanwela, Nijasri
    Nguyen, Thang H.
    Wong, K. S. Lawrence
    Chan, Bernard P. L.
    INTERNATIONAL JOURNAL OF STROKE, 2011, 6 (06) : 523 - 530